IAT Newsletter
Keep up-to-date with the IAT clinic & research in cancer treatments.Increase Your Knowledge…
IAT Clinic Cancer Research
Testimonials
Joan was diagnosed in April, 1979, after her salivary gland was excised. She came to the IAT Clinic following extensive radiation. Her prognosis was "terminal" by a well known head & neck surgeon in NYC. He gave her three options: 30% chance of survival with radical surgery of the face, jaw & tongue. Less percent with less radical surgery, or extension of life for a short period of time with radiation, only. She chose radiation, keeping her face in tact & began the IAT treatment in September of 1979...Now, 32 years later, she continues to be cancer free , thanks to the Immuno Augmentative Therapy. - J.W.“In March 2000 I was diagnosis with mesothelioma and given a few months to live. A week later my husband brought me from England, traveling in a wheelchair, to the Cancer Clinic in the Bahamas. Within a few weeks of the treatment I was much stronger, swimming in the sea and going for long walks on the beach. I have remained completely fit and healthy since then. My last 3 annual CT scans showed no growth of the cancer-HOORAY!” - S.E.
If You Or Someone You Love Have Cancer…

Phone: (242) 352-7455
Fax: (242) 352-3201
mail@immunemedicine.com
Ralph Moss PHD
Ralph W. Moss, Ph.D
“Dear Dr. Clement
It was a pleasure to visit the IAT Clinic in Freeport, Bahamas, last week. As you know, this was my fourth visit to your clinic since 1980. I have therefore had an opportunity to study the development and evolution of your clinic over the past three decades and because of my visits to cancer clinics around the world, am in good position to assess its international significance.
I consider the IAT clinic an important resource not only for Bahamians but for patients coming from the US and elsewhere. Over the past three decades it has offered treatments that are difficult for patients to otherwise access. For this reason cancer patients in the US and elsewhere are very grateful to have this treatment available to them as an option. I know that the 50,000 + subscribers to my weekly newsletter would be extremely upset if they knew that access to your program was in danger of being restricted in any way.
I want to emphasize that your treatments, while unusual, are not outside the realm of scientific inquiry. In particular, the late Dr. Lawrence Burton was ahead of his time in his emphasis on overcoming the “ blocking factors” in the serum of cancer patients. Various other scientists also described these factors and proposed ways of removing them. The famous scientists Karl Eric and Ingegard Hellstrom of Fred Hutchison Cancer Center in Seattle elucidated these blocking or suppressor factors in more than 50 peer reviewed articles (sample reference below). M. Rigdon Lentz, MD, and scientists at the University of California, Irvine, elucidated the nature of these blocking factors (reference below). They showed that these are soluble receptors to tumour necrosis factor (TNFR1 and TNFR2). A treatment based on this concept has now been given the CE mark in Europe and is available for use as treatment.
Your clinic is not alone either in its use of dendritic cell vaccine or other immunological treatments. These are similar to the treatments currently available in Germany at the Institute for Tumour Therapy in Duderstadt (Dr. Thomas Nesselhut) and the Eduardus Hospital in Colgne (Dr. Robert Gorter). It is extremely important that you make similar treatments available in the Western Hemisphere.
The reason that these treatments are not more freely available in the United States is because of the extremely restrictive regulatory environment towards new treatments created by the Food and Drug Administration (FDA). The reason for these regulations is as much economic as medical.”
There are some signs that FDA’s attitude towards new treatments is changing. FDA recently gave Orphan Drug status to the antievolution treatment of Dr. Stainlaw Burzynski of Houston, a treatment no less innovative and controversial than your own. There are signs that more changes will come from the new Obama administration. I hope that the Bahamain authorities will not move in an opposite direction during this time of change.
I sincerely hope that medical authorities in the Bahamas will not take any steps that restrict the access of their own citizens, to the innovative and scientific that you and your clinic have offered for the past thirty or so years. I feel so strongly about this that I am willing to come back to the Bahamas at your request to meet with any relevant authorities to explain the basis for this opinion.
Feel free to use this letter in whatever way you see fit.
Sincerely,
Ralph W. Moss, PhD.
www.cancerdecisions.com